Puromycin Aminonucleoside에 의해 유도된 신증후군에 대한 玉米鬚의 보호효과
Renoprotective effect of Maydis Stigma on Puromycin Aminonucleoside-induced Nephrotic Syndrome
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Nephrotic syndrome is a kidney disorder, which is characterized by proteinuria, edema (swelling), and hyperlipidemia. Maydis Stigma (Corn silk) has been widely used in Asia as a traditional medicine and is known to have a diuretic effect and is used for the treatment of edema and indigestion. Methods: The aim of this study is to investigate the improvement effect of Maydis Stigma in treating nephrotic syndrome induced by puromycin aminonucleoside. Sprague-Dawley rats were intravenously injected with 75 mg/kg/day puromycin aminonucleoside, then treated with either Losartan or 200 mg/kg/day Maydis Stigma for seven days. Results: Maydis Stigma significantly decreased ascites and proteinuria level. Plasma levels of blood urea nitrogen (BUN) and plasma creatinine reduced significantly by Maydis Stigma. In addition, treatment with Maydis Stigma attenuated histological damage. Treatment with Maydis Stigma also restored podocin expression and reduced inflammation markers such as intracellular adhesion molecules (ICAM-1), monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor alpha (TNF-α) and high-mobility group box-1 (HMGB1). Conclusions: Maydis Stigma ameliorates kidney injury in nephrotic syndrome rat models. Maydis Stigma exerts a renoprotective effect owing to its anti-inflammatory effects and reductions of ascites and proteinuria. Thus, these results indicate that Maydis Stigma is likely to be a promising agent in the treatment of nephrotic syndrome.
Abstract
Objectives: Nephrotic syndrome is a kidney disorder, which is characterized by proteinuria, edema (swelling), and hyperlipidemia. Maydis Stigma (Corn silk) has been widely used in Asia as a traditional medicine and is known to have a diuretic effect and is used for the treatment of edema and indigestion. Methods: The aim of this study is to investigate the improvement effect of Maydis Stigma in treating nephrotic syndrome induced by puromycin aminonucleoside. Sprague-Dawley rats were intravenously injected with 75 mg/kg/day puromycin aminonucleoside, then treated with either Losartan or 200 mg/kg/day Maydis Stigma for seven days. Results: Maydis Stigma significantly decreased ascites and proteinuria level. Plasma levels of blood urea nitrogen (BUN) and plasma creatinine reduced significantly by Maydis Stigma. In addition, treatment with Maydis Stigma attenuated histological damage. Treatment with Maydis Stigma also restored podocin expression and reduced inflammation markers such as intracellular adhesion molecules (ICAM-1), monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor alpha (TNF-α) and high-mobility group box-1 (HMGB1). Conclusions: Maydis Stigma ameliorates kidney injury in nephrotic syndrome rat models. Maydis Stigma exerts a renoprotective effect owing to its anti-inflammatory effects and reductions of ascites and proteinuria. Thus, these results indicate that Maydis Stigma is likely to be a promising agent in the treatment of nephrotic syndrome.
참고문헌 (32)
- Seckin I, "Experimentally induced puromycine aminonucleoside nephrosis (PAN) in rats: evaluation of angiogenic protein platelet-derived endothelial cell growth factor (PD-ECGF) expression in glomeruli", J Biomed Sci, 19(1), pp.24~ (2012)
- Orth SR, "The nephrotic syndrome", N Engl J Med, 338(17), pp.1202~1211 (1998)
- Hodson EM, "Corticosteriod therapy for nephrotic syndrome in children", Cochrane Database Syst Rev, 1, pp.CD001533~ (2005)
- Bulucu F, "Oxidative stress status in adults with nephrotic syndrome", Clin Nephrol, 53(3), pp.169~173 (2000)
- Kawachi H, "Role of podocyte slit diaphragm as a filtration barrier", Nephrology, 11(4), pp.274~281 (2006)
- Zhao X, "Kidney injury molecule-1is upregulated in renal lipotoxicity and mediates palmitate-induced tubular cell injury and inflammatory response", Int J Mol Sci, 20(14), pp.3406~ (2019)
- Hsiao WL, "The role of traditional Chinese herbal medicines in cancer therapy-from TCM theory to mechanistic insights", Planta Med, 76(11), pp.1118~1131 (2010)
- Wang W, "Nephrotic syndrome and the TCM treatment", J Tradit Chin Med, 24(3), pp.201~203 (2004)
- 김양섭, "음곡 옥미수 약침이 LPS로 유도된 흰쥐의 신장염에 미치는 영향", 대한한의학회지, 34(3), pp.25~36 (2013), 대한한의학회
- Cáceres A, "Diuretic activity of plants used for the treatment of urinary ailments in Guatemala", J Ethnopharmacol, 19(3), pp.233~245 (1987)
- Doan DD, "Studies on the individual and combined diuretic effects of four Vietnamese traditional herbal remedies (Zea mays, Imperata cylindrica, Plantago major and Orthosiphon stamineus)", J Ethnopharmacol, 36(3), pp.225~231 (1992)
- Morton JF, "Some folk-medicine plants of central american markets", Quart J Crude Drug Res, 15, pp.165~192 (1997)
- Shiraishi T, "Combination of ACE inhibitor with nicorandil provides further protection in chronic kidney disease", Am J Physiol Renal Physiol, 307(12), pp.F1313~F1322 (2014)
- Sharma R, "Thrombin-Induced Podocyte Injury Is Protease-Activated Receptor Dependent", J Am Soc Nephrol, 28(9), pp.2618~2630 (2017)
- Song H, "Glomerulosclerosis in adriamycin-induced nephrosis is accelerated by a lipid-rich diet", Pediatr Nephrol, 15(3-4), pp.196~200 (2000)
- Franceschini N, "NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: a HuGE review", Genet Med, 8(2), pp.63~75 (2006)
- Doucet A, "Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications", Pediatr Nephrol, 22(12), pp.1983~1990 (2007)
- Riedl SJ, "Molecular mechanisms of caspase regulation during apoptosis", Nat Rev Mol Cell Biol, 5(11), pp.897~907 (2004)
- Wen Y, "Yi Qi Qing Re Gao formula ameliorates puromycin aminonucleoside -induced nephrosis by suppressing inflammation and apoptosis", BMC Complement Altern Med, 15, pp.155~ (2015)
- Erdely A, "Protection against puromycin aminonucleoside-induced chronic renal disease in the Wistar-Furth rat", Am J Physiol Renal Physiol, 287(1), pp.F81~F89 (2004)
- Ahmed MM, "Diuretic and serum electrolyte regulation potential of aqueous methanolic extract of Solanum surattense fruit validates its folkloric use in dysuria", BMC Complement Altern Med, 16, pp.166~ (2016)
- Guan N, "Key molecular events in puromycin aminonucleoside nephrosis rats", Pathol Int, 54(9), pp.703~711 (2004)
- Lowenborg EK, "Glomerular function and morphology in puromycin aminonucleoside nephropathy in rats", Nephrol Dial Transplant, 15(10), pp.1547~1555 (2000)
- Coward RJ, "Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, Podocin, and CD2 associated protein in cultured human podocytes", J Am Soc Nephrol, 16(3), pp.629~637 (2005)
- Zoja C, "Progression of renal injury toward interstitial inflammation and glomerular sclerosis is dependent on abnormal protein filtration", Nephrol Dial Transplant, 30(5), pp.706~712 (2015)
- Sanz AB, "Mechanisms of renal apoptosis in health and disease", J Am Soc Nephrol, 19(9), pp.1634~1642 (2008)
- Wang Y, "Macrophages in renal disease", J Am Soc Nephrol, 22(1), pp.21~27 (2011)
- Xu X, "The role of determining the levels of serum collagen type IV in diagnosing early diabetic nephropathy", Ren Fail, 24(6), pp.747~753 (2002)
- Zhu P, "High mobility group box 1 and kidney diseases", Int J Mol Med, 31(4), pp.763~768 (2013)
- van Beijnum JR, "Convergence and amplification of toll-like receptor (TLR)and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1)", Angiogenesis, 11(1), pp.91~99 (2008)
- Zhang H, "High Mobility Group Box1 Inhibitor Glycyrrhizic Acid Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats", Kidney Blood Press Res, 42(5), pp.894~904 (2017)
- Rincon J, "Increased oxidative stress and apoptosis in acute puromycin aminonucleoside nephrosis", Int J Exp Pathol, 85(1), pp.25~33 (2004)